Long-term outcomes of ultra-hypofractionated 2 fractions single day HDR brachytherapy in localized prostate cancer

Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer

William Morris, Scott Tyldesley, S. Rodda et al. · International Journal of Radiation Oncology*Biology*Physics · 2016 · 732 citations

Medicine, Oncology, Radiation Oncology +17

Dose Escalation Improves Cancer-Related Events at 10 Years for Intermediate- and High-Risk Prostate Cancer Patients Treated With Hypofractionated High-Dose-Rate Boost and External Beam Radiotherapy

Alvaro A. Martinez, Jose A. Gonzalez, Hong Ye et al. · International Journal of Radiation Oncology*Biology*Physics · 2011 · 160 citations

Medicine, Oncology, Radiation Oncology +17

Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy

Gerard Morton, Merrylee McGuffin, Hans T. Chung et al. · Radiotherapy and Oncology · 2020 · 129 citations

Medicine, Radiation Oncology, Urology +14

High-Dose-Rate Brachytherapy as Monotherapy Delivered in Two Fractions Within One Day for Favorable/Intermediate-Risk Prostate Cancer: Preliminary Toxicity Data

Michel Ghilezan, Alvaro A. Martinez, Gary Gustason et al. · International Journal of Radiation Oncology*Biology*Physics · 2011 · 92 citations

Medicine, Oncology, Urology +14

Single-dose high-dose-rate brachytherapy compared to two and three fractions for locally advanced prostate cancer

Peter Hoskin, Ana M. Rojas, Peter Ostler et al. · Radiotherapy and Oncology · 2017 · 90 citations

Medicine, Radiation Oncology, Urology +14